Bernstein Cuts Boeing Price Target to $278 From $298 a Share
Bernstein lowered its Boeing price target to $278 per share from $298, according to analyst-rating actions published by Benzinga.
central bank decisions, rates, inflation and data releases, explained through their market impact.
stories appear here with a 15-minute delay. in real time — via the api connect the api →
Bernstein lowered its Boeing price target to $278 per share from $298, according to analyst-rating actions published by Benzinga.
Goldman Sachs kept its Sell rating on Louisiana-Pacific, according to Benzinga’s analyst-ratings coverage of the company’s shares.
Goldman Sachs reduced its price target for Tronox Holdings from $6.50 to $4.00 per share, according to Benzinga’s analyst-ratings section.
Goldman Sachs maintained Buy ratings on Installed Building, Kratos and TransDigm, while cutting the price targets for Installed Building and TransDigm.
Major steel and shipbuilding projects in Iowa and Philadelphia face labor shortages, high costs, limited space and uncertain customer demand.
Meta introduced Muse Wonder and Muse Wonder Full models for agentic tasks. Muse Wonder is available through Meta Model API; Muse Wonder Full serves Muse Code subscribers.
South Africa’s Competition Tribunal approved Woolworths’ acquisition of In2food Holdings and, with conditions, Shoprite Checkers’ purchase of Picardirebel stores.
Canaccord Genuity raised its price target for Twist Bioscience from $120 to $205 per share, according to an analyst-rating update cited by Newsmetry API.
Canaccord Genuity raised its Tempus AI price target from $80 to $95 a share while maintaining a Buy rating, Benzinga reported.
Needham lifted its Synopsys price target to $620 from $580 and kept a Buy rating, while flagging uncertainty over the GPT-Synopsys strategy.
Canaccord Genuity maintained a Buy rating on 10x Genomics and raised its price target from $60.00 to $100.00 per share.
Roth Capital reaffirmed Buy ratings on Zeta Global Holdings and Standard Motor Products, setting targets of $55 and $54, respectively, Benzinga said.
The European Commission is investigating XXXLutz’s purchase of Germany’s Porta over possible competition concerns in furniture retail across several EU states.
Bristol Myers shares fell about 3% after a lung-fibrosis trial met its goal at 60 mg but not 120 mg, while a rare-cancer study succeeded.
Micron shares fell 4.2% after reports that Chinese rival CXMT is advancing denser DRAM technology and plans to begin shipping server memory by year-end.
Evernorth’s XRP holdings lost $443 million in value between deal signing and closing as the token fell, while 80.3% of Armada shareholders took cash.
Broadcom warned that financing may become AI expansion’s biggest constraint. Its shares traded at $356.60, down about 1.4% at 10:50 EST.
Banijay Group reported purchases and sales of its own shares carried out from 5 to 9 October 2026 on Euronext Amsterdam.
Voting on Osmosis Proposal 1052 ends on 14 October 2026. Approval would raise OSMO stakers’ share of non-OSMO taker fees from 22.5% to 47.5%.
CoinMarketCal says Stacks expects Bonding Period 3 around November 10, 2026, with self-custodial Bitcoin capacity and pooled staking via partners.